New Details on the Revision of USP Chapter 1
![Granulation & Tableting - Live Online Training](files/eca/userImages/training.img/Z-ECA-Granulation-Tableting-2024-Live-Online.jpg)
Recommendation
17-19 September 2024
GMP Compliance and Technology for the Manufacture of Oral Solid Dosage Forms
As already reported in the news "Second Revision of USP Chapter <1> Injections and Implanted Drug Products (Parenterals)-Product Quality Tests", USP's Chapter <1> "Injections and Implanted Drug Products (Parenterals)-Product Quality Tests' has been revised again. New information is now available.
The USP published these details on 25 March. The revised version now contains a table of contents for a better overview whereas the Product Performance Test at the end of the Chapter has been deleted. All details about the new version of USP's Chapter <1> can be found on the USP website.
The revised Chapter will become effective on May 1st, 2016.
Related GMP News
28.08.2024FDA Warning Letter to pharmaceutical Manufacturer in Puerto Rico
06.08.2024Is it possible to remove a Biofilm in pharmaceutical Water Systems?
06.08.2024Problems in Clean Room at Contract Manufacturer of sterile Eye Preparations
31.07.2024FDA criticizes Water System at Korean Sunscreen Manufacturer
31.07.2024Containment: What is the Difference between OEB and OEL
24.07.2024EDQM publishes updated Ph.Eur. Water Monographs for comment